Peptide guide

GHK-Cu: what it is and what the research actually shows

GHK-Cu is a small natural peptide that binds copper and occurs in human blood. Every human trial found tested it as a skin cream or scalp serum, not as an injection.

Byline: Mark Sommers, editor. Sources checked 08-26-2026. Every claim below links to its PubMed record or FDA page.

Quick facts

What is in it
  • One naturally occurring peptide made of three amino acids that binds copper. It is not a blend.

One molecule, not a blend. GHK-Cu is one of the four peptides sold together in blends such as KLOW and GLOW. The studies below are about GHK-Cu tested on its own, not about any blend.

Studied for
Skin and tissue repair. Human trials looked at a copper peptide cream after laser skin resurfacing and a copper peptide scalp serum for flaking. Animal studies looked at burn healing in mice and muscle loss from cigarette smoke exposure. Every human test found was topical, a cream or a serum, not an injection.
Human evidence, part by part
GHK-CuLimited3 human studies found
Approved by the FDA?
Not an FDA-approved drug. GHK-Cu appears on FDA's list of bulk drug substances that were nominated for compounding use and then withdrawn. See where it stands.

Benefits

  • Evidence Reduced scalp flaking after 15 days in a 29-person open-label trial of a copper-peptide serum. PMID 39449909
  • Evidence Sped healing of burn wounds in mice given liposome-packaged GHK-Cu. PMID 28370978
  • Evidence Reduced smoke-related muscle loss in mice, alongside lower blood GHK-Cu levels in people with COPD. PMID 36905132
  • Suggested Discussed for skin and tissue repair generally, beyond the topical uses actually tested.
  • Suggested Promoted for injectable use, despite zero published human trials of an injected form.
  • Suggested Discussed by online clinician commentary as a tissue-remodeling peptide for hair, skin and wounds.

Evidence items link to the study behind them. Suggested items are claims in circulation, not results.

Reported side effects

  • No human safety data exists for injected GHK-Cu; every human trial tested a cream or serum on skin.
  • No skin reactions were reported in a 13-person cream trial after laser skin resurfacing. PMID 16847171
  • No adverse events were reported over 15 days in a 29-person scalp-serum trial. PMID 39449909
  • Is on FDA's list of bulk substances nominated for compounding, then withdrawn over safety concerns.

Safety, before anything else

No human safety data exists for injected GHK-Cu. Every human trial found tested a cream or a serum applied to skin, not an injection. GHK-Cu is not an FDA-approved drug and is on FDA's list of bulk substances nominated for compounding and then withdrawn, over concerns about immune reactions and impurities.

GHK-Cu

  • No skin reactions flagged in the one small trial (a cream, not an injection). PMID 16847171
  • We found no published human safety data for injected GHK-Cu.
  • No skin reactions flagged in the one small trial (a cream). PMID 16847171
  • No adverse events over 15 days of a scalp product. PMID 39449909
  • We found no published human safety data for injected GHK-Cu; all human data is topical.

We do not publish amounts or schedules of our own, on any page. The clinician commentary lower on this page quotes amounts that named clinicians state on camera, labeled and linked to the source video. Those are their words, not our guidance. Why we draw that line.

How to read the grades

Each study gets a tag. Cells in a dish means it never touched a living animal. Animals means mice or rats, usually. Small human study means a handful of people with no comparison group. Human trial means people were randomly split into treated and untreated groups, which is the only kind that can show an effect is real. Review and Systematic review sum up other studies. The full rule is on How we check.

GHK-Cu

A small natural peptide (three amino acids) that binds copper. Found in human blood; levels fall with age. Studied mostly for skin and tissue repair.

Human evidence: Limited. 3 human studies found in our search.

What has been studied

Who or what was studiedWhat was found, and the catchSource
Review
Reviews cell and gene studies suggesting GHK-Cu nudges pathways tied to tissue repair and inflammation.
Limit: Written by the peptide's discoverer; mostly lab-dish and gene data, no controlled patient outcomes.
Pickart 2018
PMID 29986520
Review
Summarizes lab evidence that GHK can raise collagen and other skin-structure molecules.
Limit: Same author group; no controlled human trial evaluated.
Pickart 2015
PMID 26236730
Human trial
n = 13 people
After laser skin resurfacing, a copper-peptide cream did not beat control on measured redness or wrinkles; patients did report liking it more.
Limit: Thirteen people, a skin cream, and the only win was a satisfaction score.
Miller 2006
PMID 16847171
Review
Questions whether GHK in skin products reaches where it would need to act, and calls the effectiveness data thin and inconsistent.
Limit: Narrative review.
Mortazavi 2025
PMID 39963574
Animals
GHK-Cu packed into liposomes sped healing of scald burns in mice.
Limit: Burn model, and a special delivery form rather than plain GHK-Cu.
Wang 2017
PMID 28370978
Small human study
n = 20 (blood levels only)
People with COPD had lower blood GHK; in mice, GHK-Cu reduced smoke-related muscle loss.
Limit: The human part only measured blood levels; the treatment effect is in mice.
Deng 2023
PMID 36905132
Small human study
n = 29 people
A scalp routine with a copper-peptide serum plus a scrub reduced flaking over 15 days.
Limit: No control group, company-employed authors, peptide mixed with other actives.
Patel 2024
PMID 39449909

Safety signals in the studies

  • No skin reactions flagged in the one small trial (a cream, not an injection). PMID 16847171
  • We found no published human safety data for injected GHK-Cu.
  • No skin reactions flagged in the one small trial (a cream). PMID 16847171
  • No adverse events over 15 days of a scalp product. PMID 39449909
  • We found no published human safety data for injected GHK-Cu; all human data is topical.

Most cited author in this list: Pickart, 2 of 7 sources. When a small number of groups produce most of the evidence, independent replication is thinner than the source count suggests.

Where it stands with regulators

  • GHK-Cu appears on FDA's list of bulk drug substances nominated for compounding and then withdrawn, under the heading Bulk drug substances nominated but withdrawn. FDA's stated concern: compounded injectable drugs containing GHK-Cu may pose risk for immune reactions due to possible aggregation and peptide related impurities, and human data are limited. Page content current as of 04/22/2026, checked 08-26-2026. Source

What is missing

No human study of injected GHK-Cu was found. Every human data point comes from a cream or a serum applied to skin, not an injection. The two human trials are small, 13 and 29 people, and one had no control group. Most of the mechanism claims about repair and inflammation come from gene and cell-dish studies, not from patients.

Clinician commentary (YouTube)

This is commentary, not evidence. 4 clinicians with large audiences discuss this on camera. Each video below is summarized in our words and linked so you can watch the source yourself. Any amounts mentioned are what the named clinician says on camera, not PeptideGauge guidance. The graded studies above remain the record of what is known. How this layer works.

Dr. Alex Tatem

In “GHK-Cu: The Peptide Everyone Is Injecting (Big Mistake?)”, Dr. Alex Tatem discusses GHK-Cu. What he says, in short:

  • He says GHK-Cu is a naturally occurring tripeptide plus copper that the body already makes, with plasma levels around 200 ng/mL at age 20 dropping to about 80 ng/mL by age 60.
  • He traces its discovery to biochemist Dr. Loren Pickart in 1973, who found that plasma from young donors made old liver cells behave young again, and later isolated GHK-Cu as the responsible factor.
  • He says it can influence over 4,000 human genes and stimulates collagen synthesis at extremely low, picomolar concentrations.
  • He states there are real published human studies on the topical form, but zero published human clinical trials on the injectable form for any indication.
  • He warns that injecting it bypasses the body's normal copper regulation, citing a typical 2 mg injectable dose as delivering about 0.32 mg of elemental copper, above the EFSA daily safe copper intake limit.
  • He notes RFK Jr.'s February 2026 announcement that injectable GHK-Cu could move back to a legally compoundable FDA category, but stresses no formal FDA rule has actually been issued yet.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Alex Tatem’s, not ours.

In “The Truth About Popular Peptides (What Works, What’s Overhyped) | Peptide Tier List pt.1”, Dr. Alex Tatem discusses GHK-Cu. What he says, in short:

  • He explains GHK-Cu gets its name from glycine, histidine, lysine, and the copper that helps deliver it.
  • He says there's a lot of data supporting the topical form for skin tone, hydration, and collagen repair, but the literature on injecting it subcutaneously is extremely sparse.
  • He compares it to ketoconazole, a drug that's safe as a topical shampoo but causes liver failure if swallowed, as a caution that working topically doesn't guarantee a drug works the same way injected.
  • He says support mostly comes from biohackers rather than clinical trials, but calls the anecdotes he's seen universally positive, including friends who run it year round with photos to back up results.
  • He rates GHK-Cu a solid A, saying it seems safe and effective anecdotally even without high quality clinical evidence.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Alex Tatem’s, not ours.

1 more video where Dr. Alex Tatem covers GHK-Cu

In “Every Popular Peptide Ranked | GLP-1, Growth Hormone, HCG, NAD+, IGF-1, Peptide Tier List”, Dr. Alex Tatem discusses GHK-Cu. What he says, in short:

  • He says GHK-Cu, made of glycine, histidine, lysine and copper, has solid topical dermatology data for skin tone, hydration, and collagen, and is now being used subcutaneously for a more systemic effect.
  • He cautions that a drug being safe topically doesn't guarantee it's safe injected, comparing it to topical ketoconazole causing liver failure if swallowed, though he says no such adverse signal has shown up with GHK-Cu.
  • He says clinical literature is sparse and support mostly comes from biohacker anecdotes, but calls those anecdotes universally positive, better than what he sees for BPC-157 or TB-500, and gives it an A tier ranking.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Alex Tatem’s, not ours.

Dr. Ashley Froese

In “Dr. Admits - I Was WRONG AGAIN About GHK-Cu”, Dr. Ashley Froese discusses GHK-Cu. What she says, in short:

  • She explains GHK copper is a naturally occurring three amino acid fragment that binds copper, released when the body breaks down type 1 collagen and the SPARC protein during tissue remodeling.
  • She says blood GHK levels drop about 60% by age 60, and frames this decline as both a symptom and a driver of aging since less GHK means less copper reaching repair sites.
  • She says GHK copper delivers copper to enzymes involved in antioxidant defense, collagen and elastin cross linking, and new blood vessel formation for wound healing.
  • She cites research that GHK copper influences over 4,000 genes, about 30% of the genome, turning up DNA repair, antioxidant, and stem cell activity genes while turning down inflammatory and cancer linked genes, with effects reportedly lasting days despite a 30 to 60 minute half life in blood.
  • She cites human research showing topical GHK copper increases skin density and thickness and outperformed vitamin C and retinoic acid for stimulating collagen, plus animal data on faster wound healing, and notes the FDA is reevaluating injectable GHK copper for wound healing, dermal atrophy, COPD and lung remodeling, and hair restoration.
  • She flags safety concerns including copper overload, zinc depletion with long term high dose use, and a theoretical concern that its blood vessel forming effect could feed a tumor.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Ashley Froese’s, not ours.

In “KLOW - Dr Explains The Peptide Stack For Healing, Inflammation and Regeneration”, Dr. Ashley Froese discusses GHK-Cu. What she says, in short:

  • She describes GHK-copper as a copper delivery peptide that carries copper into cells to power enzymes that crosslink collagen and elastin, giving tissue strength and elasticity.
  • She says it tells the body to break down stiff, scar-like collagen and rebuild it with healthier new fibers, and switches on thousands of repair-related genes while calming inflammation.
  • She says adding GHK-copper to the Wolverine stack (BPC-157 and TB-500) creates the Glow stack, together covering blood supply, cell migration, and structural rebuild.
  • She warns that copper toxicity is a real, though not common, risk if people assume more injected peptide is always better.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Ashley Froese’s, not ours.

1 more video where Dr. Ashley Froese covers GHK-Cu

In “Real Doctor: If I Started Peptides Today, I'd Do THIS (The Ultimate Peptide Roadmap)”, Dr. Ashley Froese discusses GHK-Cu. What she says, in short:

  • She brings in GHK copper after repair and inflammation are handled, when someone wants better skin or hair.
  • She says most people know it as the skin peptide, but thinks that undersells it, calling it more of a tissue remodeling peptide.
  • She says research shows it can improve collagen, skin, and wound healing, and is even being shown to regenerate hair follicles.
  • She notes GHK copper is the reason she calls the combination with BPC 157 and TB 500 the glow stack.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Ashley Froese’s, not ours.

Dr. Craig Koniver

Dr. Craig Koniver does not run a channel of his own. Each video below is an interview published by the show that recorded it.

In “Is Peptide Therapy the Future of Medicine? | Dr. Craig Koniver” on The Ancient Health Podcast, Dr. Craig Koniver discusses GHK-Cu. What he says, in short:

  • He says GHK copper grew up in the wound healing world and is used a lot aesthetically because it helps skin repair and regenerate quickly.
  • He says that probably has to do with dropping in copper, and states his view that most of us are copper deficient.
  • He calls it a great way to get copper into the system.
  • He says there is also a very strong anti-inflammatory and immune modulating effect from GHK copper.
  • He lists it as the fourth peptide on his immune and inflammation list, after thymosin alpha-1, BPC-157 and KPV.

ghk copper kind of grew up in the wound healing World um it's used a lot aesthetically because it helps the skin repair regenerate really quickly

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Craig Koniver’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

In “Dr. Craig Koniver: Health Optimization with Peptides, Light Therapy, and Methylene Blue” on Health Optimization Medicine Podcast, Dr. Craig Koniver discusses GHK-Cu. What he says, in short:

  • He calls GHK-Cu one of his clinic's favorite peptides and says they use it topically, intravenously and subcutaneously.
  • He says it also has a longevity effect and repairs DNA.
  • He explains his interest in the copper itself, saying copper is needed at the fifth cytochrome where ATP is made and that most people are more copper deficient than they realize.
  • He describes an interplay between iron and copper, saying people assumed to have too little iron probably have too much as a result of too little copper, and credits Morley Robbins and the root cause protocol for what he learned there.
  • He says GHK copper is a great way to get copper stores back, on top of its benefits for skin, wound healing and collagen.
  • He says it is very anti-inflammatory, that they can use quite big doses, and that they reach for it in healing cases including long COVID.
  • He says his wife runs the aesthetics side of the practice and uses it topically after laser procedures to help skin heal faster.

It's It's one of our favorite peptides, for sure. Um it also has kind of a longevity effect. It repairs DNA.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Craig Koniver’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

1 more video where Dr. Craig Koniver covers GHK-Cu

In “Episode 95: Dr. Craig Koniver - Founder of Koniver Wellness, Performance Medicine Expert” on Habits & Hustle w/ Jennifer Cohen, Dr. Craig Koniver discusses GHK-Cu. What he says, in short:

  • He puts GHK-Cu in the cosmetic peptide group and says it grew up in the wound healing world.
  • He says he uses it alongside aesthetic procedures including lasers, Botox and fillers.
  • He says that if you use PRP in the scalp, adding GHK copper systemically gets you a better result.
  • He says its action has to do with copper exchange, which has to do with wound healing, so it accelerates wound healing.
  • He says the same efficiency applies at the cell level as on the skin, making the recovery process from damage or injury more efficient.
  • He also calls it a longevity peptide, saying it has different parts to it.

it has to do with copper it has to do with copper exchange which has to do with wound healing so it accelerates wound healing

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Craig Koniver’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

Dr. Jones, DC

In “Doctor Reacts to Most Powerful Peptide Stacks (GLOW, KLOW & Wolverine)”, Dr. Jones, DC discusses GHK-Cu. What he says, in short:

  • He calls GHK-Cu the collagen powerhouse and says it stimulates collagen production, promotes wound healing, and has skin regeneration properties.
  • He says it is what produces the visible glow, reduced fine line development, and the plumpness people want back after weight loss.
  • He calls it possibly the most underrated peptide of the ones he covers.
  • He says it is also the most common culprit behind injection site welts, stinging, and red marks, explaining that its chemistry can irritate the fat layer under the skin depending on concentration.
  • He says raising the dilution to four or five milliliters, splitting the dose into two smaller injections, using a shorter needle, and injecting over 10 to 15 seconds can reduce those reactions.
  • He describes around 2 milligrams a day inside his clinic's GLOW protocol and complains that online recommendations run from 2 milligrams to 20 with no standardization.

I think GHK copper might be the most underrated peptide that we're talking about today.

Increasing the dilution to maybe four or 5 mls can help in that situation.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

In “This Peptide Stack Prevents or Fixes Ozempic Face Fast! (Doctor Explains)”, Dr. Jones, DC discusses GHK-Cu. What he says, in short:

  • He describes GHK-Cu as a copper peptide of three amino acids whose job is to signal, specifically telling skin to ramp up collagen and elastin.
  • He says people running it for facial rejuvenation use it either topically at a fraction of a percent or injectable in what he calls the low milligram range, with some going higher for a more aggressive push.
  • He says more is not necessarily better with this peptide.
  • He argues the signal is only as good as the tissue it is signaling into, which is his whole case for stacking it rather than running it alone.
  • He says copper peptides are known to irritate tissue and that a brief burning or stinging at the site is expected rather than a sign something is wrong.
  • He says diluting properly, letting it come to room temperature, using a small gauge needle, rotating sites, and injecting slowly all reduce the sting.

they're running it injectable in the low milligram range

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

6 more videos where Dr. Jones, DC covers GHK-Cu

In “Doctor Reveals The ONLY Peptide That Builds Collagen, Muscle & Hair (GHK CU)”, Dr. Jones, DC discusses GHK-Cu. What he says, in short:

  • He describes GHK-Cu as a naturally occurring copper peptide and says levels run about 200 nanograms per milliliter at age 20 and drop to about 80 by age 60.
  • He lays out four mechanisms: reducing inflammation markers such as TNF and IL-6, boosting the body's own glutathione and superoxide dismutase, activating stem cells via markers including p63, and driving wound healing through angiogenesis.
  • He describes a range of 2 to 5 milligrams daily as a subcutaneous injection for general longevity, taken in the morning, and calls it a several month protocol rather than a several week one.
  • He says he started it himself about six months ago for shoulder and back issues and noticed skin texture and elasticity changes at four to six weeks and faster head hair growth around eight to twelve weeks, which he presents as personal anecdote.
  • He says it is not a muscle building peptide and that what it actually does is support recovery and repair training damage, with his own soreness dropping from four or five days to two or three.
  • He says the peptide only supplies the signal and that vitamin C at about 1,000 milligrams, glycine, proline, and about 30 grams of collagen peptides daily supply the building blocks.
  • He says most people notice improvements within four to eight weeks with deeper changes at three to six months, and that hair needs three to six months because a full growth cycle has to complete.
  • He says it works best as prevention or early intervention for hair, because regrowth is harder than preservation.

By age 60, that drops to 80. That's a 60% decline.

GHK copper is optimization, not magic.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

In “GHK-Cu for GLP-1 Users - Preventing Ozempic Face, Hair Loss & Muscle Loss”, Dr. Jones, DC discusses GHK-Cu. What he says, in short:

  • He positions GHK-Cu as the one peptide he says protects against facial volume loss, hair thinning, and muscle loss on GLP-1 medications at the same time.
  • He cites Broad Institute work saying it modulates 31.2 percent of the human genome, over 4,000 genes, upregulating collagen synthesis, DNA repair, and antioxidant defense while downregulating inflammatory genes.
  • He describes a prevention protocol of 2 to 3 milligrams daily by subcutaneous injection, run for months rather than weeks, and says the same dose covers the skin, hair, and recovery uses.
  • He says it should be started with the GLP-1 rather than after facial changes are visible, and that prevention is far more successful than reversal.
  • He says he has used it himself for about six months starting at about 2 milligrams every day, originally for shoulder recovery from volleyball training.
  • He states plainly that there are zero studies specifically testing GHK-Cu for Ozempic face or GLP-1 induced side effects and that he is extrapolating from wound healing research, gene modulation data, and clinical observation.
  • He says the peptide is only tier one of five and that without protein targets, collagen, topicals, training, and lifestyle he considers the money wasted.

Two to three milligrams daily subcutaneous injection.

I'm extrapolating from mechanisms and clinical experience here, not from specific GLP-1 trials.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

In “Doctor Explains GHK-Cu the Glow & Grow Peptide”, Dr. Jones, DC discusses GHK-Cu. What he says, in short:

  • He describes GHK-Cu as glycine, histidine, and lysine with a copper atom locked on, calling the peptide the courier and the copper the package it delivers.
  • He says the body releases it at injury sites as one of the first repair flares, and credits Lauren Pickart with identifying it in the 1970s.
  • He argues people file it wrongly as a beauty peptide and calls it a master signal for tissue protection that works upstream on thousands of genes.
  • He says the delivery route is the decision that makes or breaks results, and that the only criterion is how deep the target tissue is: topical for surface skin, microneedling for dermal remodeling, injection for systemic, hair, tendon, and joint targets.
  • He refuses to give a dose on camera, saying there is no single number because it depends on route and goal, and that past a certain point you are saturating the signal rather than getting extra repair.
  • He warns that copper toxicity is a real thing and says consistency at a sane dose beats mega dosing every time.
  • He discloses that it did not regrow his own hair.
  • He says it will do almost nothing on a foundation of an inflammatory diet, poor sleep, and inadequate protein, comparing it to shouting orders at a crew that never showed up.

There is no single number because the right amount is probably a function of your route and what you're chasing.

And yes, before you ask me, I tried to regrow my hair with GHK copper. No, unfortunately, didn't work for me.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

In “The Benefits & Risks of GHK-Cu (WATCH BEFORE TAKING)”, Dr. Jones, DC discusses GHK-Cu. What he says, in short:

  • He says GHK-Cu levels fall to roughly a third by age 50 or 60 and calls that gap the opportunity.
  • He describes four levers: dialing down TNF and IL-6 in preclinical models, upregulating the body's own antioxidant production, waking dormant repair cells with markers including p63, and signaling collagen types 1 and 3 plus elastin.
  • He calls skin firmness and texture the most reliable outcome he sees, typically at four to eight or twelve weeks with deeper remodeling at three to six months, while stating outright that there are no trials demonstrating those outcomes and that this is clinical observation.
  • He tells viewers to calibrate expectations on hair, saying it is not first line for baldness and is more often one piece of a larger program.
  • He says at the doses people are supposed to use the copper content appears well below toxicity thresholds and that the safety margin looks substantial.
  • He says the FDA placed it in category two citing limited human data and immunogenicity risk, and argues that concern is about aggregation and impurities in poorly made product rather than the molecule itself.
  • He says the cancer and IGF concerns attached to growth hormone peptides do not apply because it works through a different mechanism.
  • He says copper does not blend well with other peptides in a single vial, that the technically correct approach for maximum results is separate injections, and he discloses that his clinic sells blends and discusses the trade-off with patients.

The FDA put GHK copper in category two, citing limited human data and immunogenicity risk.

It's a quality control issue, not a GHK copper issue.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

In “Doctor Reveals The 10 Most POWERFUL Peptide Stacks (Science Backed Peptides)”, Dr. Jones, DC discusses GHK-Cu. What he says, in short:

  • He describes GHK-Cu as usable topically or by injection and says copper is essential for building the skin matrix components that keep skin firm and elastic.
  • He says most of his patients use the topical cream, a pea sized amount applied to face and neck daily.
  • He says for systemic anti-aging his doctors prescribe the injectable at usually somewhere between 1 and 1.5 milligrams daily, and that he typically sees patients on a three month cycle before a break.
  • He says most patients report visible skin improvement typically between 8 and 12 weeks, with some earlier and some later depending on age and skin condition.
  • He describes the expected changes as smoother texture, better tone, and reduced fine lines, and says it is not overnight magic but the changes are real.
  • He frames the topical versus injectable choice as cosmetic versus systemic and says the prescribing doctor should pick based on the individual's goals.

usually somewhere between 1 to one and a half milligrams daily

Most patients we work with report a visible skin improvement typically between 8 to 12 weeks.

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

In “Stack Retatrutide & These 2 Peptides to STOP The Aging Clock (GHK-Cu, MOTS-c)”, Dr. Jones, DC discusses GHK-Cu. What he says, in short:

  • He assigns GHK-Cu to what he calls the gene expression hand of aging, one of three clocks he says move at the same time.
  • He says it works upstream rather than suppressing a symptom or pushing a hormone, dialing repair genes back up and inflammation genes down.
  • He says natural GHK levels typically drop from about 200 nanograms per milliliter to about 80 by age 60.
  • He describes a pattern he sees in patients over 50 who eat clean and lift four days a week and still have thinning skin, less dense hair, and joints that do not recover, and says nobody had told them about that decline.
  • He says a research chemical cream picked up from a Reddit recommendation does not address that, and argues it needs pharmaceutical grade material dosed correctly, without naming a number on camera.
  • He says repair genes coming back online is only half of it, because repair work costs energy and stalls if the mitochondrial side is not keeping up.

GHK copper is the peptide that intervenes at that level. It doesn't suppress a symptom. It doesn't push a hormone. It works upstream.

their natural GHK levels have typically dropped from 200 ng per ml down to 80

Link checked 08-26-2026. The summary is our paraphrase; the claims are Dr. Jones, DC’s, not ours. Quoted lines are taken from the automatic captions on the video, so the wording can differ slightly from the audio.

Common questions

Is GHK-Cu approved by the FDA?

No. It is not an FDA-approved drug. It is on FDA's list of bulk drug substances that were nominated for compounding use and then withdrawn, over concerns about immune reactions and impurities.

What has GHK-Cu actually been tested in people for?

Two small human trials were found. One tested a copper peptide cream after laser skin resurfacing, in 13 people, and did not beat a control cream on measured redness or wrinkles, though patients said they liked it more. The other tested a scalp serum in 29 people and reported less flaking after 15 days, with no control group.

Has anyone tested injected GHK-Cu in people?

No human study of an injected form was found. Every human trial applied GHK-Cu to the skin or scalp as a cream or serum.

Why are the claims for it bigger than the human studies show?

Most of the evidence for GHK-Cu comes from lab-dish and mouse studies about gene activity, collagen and burn healing, not from patients. Reviews summarizing that work are often what gets cited, even though they are not controlled human trials.

Is GHK-Cu safe?

There is no published human safety data for an injected form. The two small topical trials reported no skin reactions, but a cream or serum on skin is not the same as an injection into the body, so that cannot be used to say an injection is safe.

Is GHK-Cu found naturally in the body?

Yes. It is a peptide present in human blood that binds copper, and blood levels are reported to fall with age. That natural presence does not by itself tell us whether adding more, or injecting it, does anything useful.

What is the difference between GHK-Cu alone and blends like KLOW or GLOW?

Blends mix GHK-Cu with other peptides that each have their own separate research. No study has tested any of these blends as a whole, so a study of GHK-Cu alone is not evidence about what the mixed product does.

Sources

  1. Deng (2023). PMID 36905132
  2. Miller (2006). PMID 16847171
  3. Mortazavi (2025). PMID 39963574
  4. Patel (2024). PMID 39449909
  5. Pickart (2015). PMID 26236730
  6. Pickart (2018). PMID 29986520
  7. Wang (2017). PMID 28370978

GHK-Cu appears on the FDA list of bulk drug substances nominated for compounding and then withdrawn, under the heading Bulk drug substances nominated but withdrawn, over concerns about immune reactions, peptide related impurities and limited human data. It is not an FDA-approved drug. Checked 08-26-2026.

Want these studies next to every other one on the site?

Open the evidence table

Mixing a vial? Do the math with the calculator.

Open the calculator